CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 90 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -37.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +60.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | +50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -60.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $8,000 | -38.5% | 2,000 | -33.3% | 0.00% | – |
| Q1 2015 | $13,000 | -7.1% | 3,000 | -45.5% | 0.00% | – |
| Q2 2014 | $14,000 | +16.7% | 5,500 | 0.0% | 0.00% | – |
| Q1 2014 | $12,000 | -29.4% | 5,500 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $17,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |